Celyad SA Sponsored ADR
(NASDAQ : CYAD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.99%174.950.4%$344.99m
AMRNAmarin Corporation Plc Sponsored ADR
-3.78%16.062.0%$149.53m
JAZZJazz Pharmaceuticals Plc
-1.08%140.562.2%$114.91m
PRGOPerrigo Co. Plc
-2.58%57.006.8%$67.38m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.10%119.536.3%$53.66m
MNKMallinckrodt Plc
-7.64%19.2321.1%$53.07m
ICLRICON Plc
-1.99%133.504.1%$46.79m
UTHRUnited Therapeutics Corporation
-2.05%107.8914.4%$42.00m
ICPTIntercept Pharmaceuticals, Inc.
-0.07%108.0118.6%$39.25m
SAGESAGE Therapeutics, Inc.
1.36%101.999.6%$36.88m
HZNPHorizon Pharma plc
0.25%19.937.4%$35.80m
ENDPEndo International Plc
-8.53%10.198.9%$33.99m
CTLTCatalent Inc
-3.91%34.642.4%$30.89m
MDCOMedicines Company
-3.54%19.0621.8%$26.60m
ZGNXZogenix, Inc.
-1.03%41.449.9%$24.77m

Company Profile

Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.